To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
BDC Capital’s growth equity arm backs Genacol Group
BDC Capital’s growth equity division has invested in The Genacol Group, a Montreal-based company specializing in natural supplements for joint health.
